Ligand Pharmaceuticals reported $33M in Stock for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Amgen AMGN:US $ 4152M 37M
Arena Pharmaceuticals ARNA:US $ 0M 0M
Baxter International BAX:US $ 2025M 40M
Bristol Myers Squibb BMY:US $ 2163M 26M
Clovis Oncology CLVS:US $ 17.28M 7.72M
Eli Lilly And LLY:US $ 3907.4M 82.5M
Endo International Ordinary Shares ENDP:US $ 297.3M 41.15M
Flexion Therapeutics FLXN:US $ 14.67M 2.37M
Gilead Sciences GILD:US $ 2797M 191M
GlaxoSmithKline GSK:LN 6244M 86M
Harsco HSC:US $ 163.07M 5.46M
Heron Therapeutics HRTX:US $ 41.5M 1.3M
Intrexon XON:US $ 9.94M 1.48M
Karyopharm Therapeutics KPTI:US $ 3.94M 38K
Lannett LCI:US $ 112.64M 3.09M
Ligand Pharmaceuticals LGND:US $ 33M 6.95M
Pacira Pharmaceuticals PCRX:US $ 67.21M 1.94M
Teva Pharmaceutical Industries TEVA:US $ 4167M 195M
Veracyte VCYT:US $ 9.82M 3.15M